Chemical Compound
Amenamevir; 2H-Thiopyran-4-carboxamide, N-(2,6-dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-, 1,1-dioxide; ASP 2151; Amenamevir; N-(2,6-Dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-2H-thiopyr
CAS Registry Number
841301-32-4
Primary record
Amenamevir; 2H-Thiopyran-4-carboxamide, N-(2,6-dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-, 1,1-dioxide; ASP 2151; Amenamevir; N-(2,6-Dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-2H-thiopyr
- 库存
- 8,656 克
- 纯度
- 99.6 %
- CAS
- 841301-32-4
化合物标识与属性
- CAS
- 841301-32-4
- PubChem CID
- 11397521
- SMILES
- CC1=C(C(=CC=C1)C)N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CCS(=O)(=O)CC4
- Canonical SMILES
- Cc1cccc(C)c1N(CC(=O)Nc1ccc(-c2ncon2)cc1)C(=O)C1CCS(=O)(=O)CC1
名称与同义词
- Amenamevir
- ASP 2151
- 841301-32-4
- amenalief
- amenamevirum
- Amenamevir [INN]
- Amenamevir?
- ASP2151
- Amenalief (TN)
- UNII-94X46KW4AE
- Amenamevir (Standard)
- A1BXD
- AMENAMEVIR [MI]
- Amenamevir (JAN/INN)
- AMENAMEVIR [JAN]
- RefChem:556930
- 94X46KW4AE
- D07PXQ
- ASP-2151
- AMENAMEVIR [WHO-DD]
- DTXSID101027753
- orb1303043
- SCHEMBL2238614
- CHEMBL4297592
- C24H26N4O5S
- J05AX26
- MFCD19443709
- DTXCID601513329
- HMS5084B18
- BCP29135
- EX-A1700
- RIB30132
- HY-14809R
- s5552
- AKOS032954202
- CCG-269570
- CS-8093
- DB11701
- SB19732
- CID11397521
- NCGC00538163-01
- AC-35855
- AK688795
- BS-17608
- CID 11397521
- DA-60976
- HY-14809
- SY274088
- N-(2-((4-(1,2,4-oxadiazol-3-yl)phenyl)amino)-2-oxoethyl)-N-(2,6-dimethylphenyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide
- NS00072161
- A13180
- D10564
- D84108
- A969304
- A1039026
- Q27271708
- Helicase-primase inhibitor (herpes infection), Astellas
- N-(2,6-dimethylphenyl)-N-[2-[4-(1,2,4-oxadiazol-3-yl)anilino]-2-oxoethyl]-1,1-dioxothiane-4-carboxamide
- B0084-459784
- N-(2,6-DIMETHYLPHENYL)-N-(2-((4-(1,2,4-OXADIAZOL-3-YL)PHENYL)AMINO)-2-OXOETHYL)-1,1-DIOXOTHIANE-4-CARBOXAMIDE
- N-(2,6-dimethylphenyl)-N-[2-[4-(1,2,4-oxadiazol-3-yl)anilino]-2-oxo-ethyl]-1,1-dioxo-thiane-4-carboxamide
- 2688070-43-9
- Amenamevir; 2H-Thiopyran-4-carboxamide, N-(2,6-dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-, 1,1-dioxide; ASP 2151; Amenamevir; N-(2,6-Dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-2H-thiopyr
- ASP 2151; N-(2-((4-(1,2,4-oxadiazol-3-yl)phenyl)amino)-2-oxoethyl)-N-(2,6-dimethylphenyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide
- N-(2,6-dimethylphenyl)-N-(2-(4-(1,2,4-oxadiazol-3-yl)anilino)-2-oxoethyl)-1,1-dioxothiane-4-carboxamide
- N-(2,6-Dimethylphenyl)-N-(2-{[4-(1,2,4-oxadiazol-3-yl)phenyl]amino}-2-oxoethyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide
- N-(2,6-dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-2H-thiopyran-4-carboxamide 1,1-dioxide
- N-[2-[[4-(1,2,4-Oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-N-(2,6-dimethylphenyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-Dioxide